Many companies were screened out because performance has faltered or because of limited history.  Read the full lists below at BioHealthInvestor.com:

• Outlook 2011: ARIA, CHTP, CYCC, ENMD, EXAS, EXEL, FOLD, IDIX
• Outlook 2011, Part II: AMRN, ILMN, INHX, JAZZ, NBIX, NPSP, THRX, VPHM

Stocks covered above in detail at BioHealthInvestor.com are ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Chelsea Therapeutics International Ltd. (NASDAQ: CHTP), Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), EntreMed Inc. (NASDAQ: ENMD), Exact Sciences Corporation (NASDAQ: EXAS), Exelixis, Inc. (NASDAQ: EXEL), Amicus Therapeutics, Inc. (NASDAQ: FOLD), Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), Amarin Corporation plc (NASDAQ: AMRN), Illumina Inc. (NASDAQ: ILMN), Inhibitex Inc. (NASDAQ: INHX), Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), Neurocrine Biosciences Inc. (NASDAQ: NBIX), NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), Theravance Inc. (NASDAQ: THRX), and ViroPharma Inc. (NASDAQ: VPHM).

You can also see the same sort of search from 2009 for the 2010 outlook that was done at BioHealthInvestor.com.

JON C. OGG

Alcoa Inc. (NYSE: AA) Raised to Overweight at JPMorgan.
Amazon.com Inc. (NASDAQ: AMZN) Maintained Buy but removed from Conviction Buy List at Goldman Sachs.
Expedia Inc. (NASDAQ: EXPE) Cut to Neutral at Goldman Sachs.
Yingli Green Energy (NYSE: YGE) Cut to Perform at Oppenheimer.
J.C. Penney Company, Inc. (NYSE: JCP) Cut to Hold at S&P Equity Research (late Thursday call).
Jinko Solar (NYSE: JKS) Cut to Perform at Oppenheimer.
Motorola Inc. (NYSE: MOT) Cut to Hold with $10 target at Citigroup.
Neurocrine Biosciences (NASDAQ: NBIX) Started as Buy at Jefferies.
QLogic Corp. (NASDAQ: QLGC) Raised to Buy at Canaccord.
ScanSource Inc. (NASDAQ: SCSC) Raised to Buy at Stifel Nicolaus.
Solarfun Power Holdings Co. (NASDAQ: SOLF) Cut to Hold with $13 target at Auriga.
Vale S.A. (NYSE: VALE) Cut to Neutral at UBS.
ViaSat Inc. (NASDAQ: VSAT) Raised to Outperform at Oppenheimer.
VMware Inc. (NYSE: VMW) Started as Market Perform at FBR.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

AngloGold Ashanti Ltd. (NYSE: AU) was down 4.5% at $44.62 on over 500,000 shares after a mine accident closed down a mine after a worker’s death.

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is down after its weight loss drug candidate is in trouble.  Shares are down 6.8% at $3.85 on over 200,000 shares.

Beazer Homes USA Inc. (NYSE: BZH) is down after saying that it might miss order expectations this quarter and cut estimates for the year on land costs.  Shares are down 4.6% at $4.33 on thin volume.

Harbor BioSciences, Inc (NASDAQ: HRBR) is soaring by 60% at $0.38 after its prostate cancer drug shows partial overall response.

Level 3 Communications Inc. (NASDAQ: LVLT) is recovering after pricing its $175 million 6.5% Convertible Senior Notes due 2016 with an initial conversion price of $1.235 per share.  Shares were hit yesterday but the stock is up 4.25 at $0.99 on recovery mode after an obvious Over-Sale yesterday.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is down after its major depressive disorder drug candidate was ineffective.  Shares were down by 9.6% at $5.65 on more than 300,000 shares last night and shares are trading around $5.67 on last look this morning.

Novell, Inc. (NASDAQ: NOVL) is up on word that it may sell the company in two parts; sshares are up 6% around $5.90 on close to 1 million shares.

Savient Pharmaceuticals Inc. (NASDAQ: SVNT) is soaring after the FDA finally approvedits gout drug, about a year or two later than many expected.  Shares are up 27% at $18.81 on more than 1 million shares.

UTStarcom, Inc. (NASDAQ: UTSI) is up 7.25% at $2.07 after the company announced a contract from Jinan, Shandong Province to accelerate its network transformation and integration.

Radware Ltd. (NASDAQ: RDWR) was yesterday’s big rumor move higher but shares are down slightly this morning.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

First Solar Inc. (NASDAQ: FSLR) is trading higher after Credit Suisse upgraded the solar player to Outperform from Neutral and gave it a $150 target price.  Shares are up 4.4% at $124.02 this morning.

Fannie & Freddie are at it again…. Fannie Mae (NYSE: FNM) is down another 14% at $0.48 on active volume and Freddie Mac (NYSE: FRE) is trading down 13% at $0.65 on slightly less volume.  This is after large price drops yesterday based upon the FHFA requesting delisting from the NYSE.

Neurocrine Biosciences Inc. (NASDAQ: NBIX) is trading up 4.3% at $5.60 after it and Boehringer announced a pact to develop diabetes drug that is a small molecule GPR119 agonist for the treatment of Type II diabetes and other indications.  That is after the Abbott deal yesterday.

Discovery Laboratories Inc. (NASDAQ: DSCO) is down 15% after a common stock and warrant offering was proposed a day after it received financing from Kingsbridge Capital.

Oncothyreon Inc (NASDAQ: ONTY) is up 20% at $4.35 after the company announced that Merck-Serono is resuming the Stimuvax clinical program in lung cancer.

NVIDIA Corporation (NASDAQ: NVDA) is trading up after Jim Cramer gave the company a Buy signal last night on CNBC’s MAD MONEY.  Shares closed at $11.77 and are up about 3.1% at $12.14 this morning on more than 50,000 shares.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Sponsor: 5 best investments for 2010 – The next nine months represent a bold new era for investors.

24/7 Wall St. will look at the Twitter posts at Reuters Biz, WSJ, Financial Times, CNN Money, MarketWatch, CNBC, and 24/7 Wall St. each day to see which stocks are most frequently mentioned. It is clear that in this area of social media these tweet are a sign of which companies the Twitter universe is interested in. These financial sites are followed by a combined 625,000 Twitter users which makes them a sizeable sample of Wall St.’s interests. In some cases, we will publish the actual tweets from the sites.

Among the most tweeted stocks on market aggregator Top Stock Tweets include EURUSD, GBPUSD, USDCHF, BP p.l.c. (NYSE: BP), Apple Inc. (NASDAQ: AAPL), Xoma Ltd (NASDAQ: XOMA), Google Inc. (NYSE: GOOG), Neurocrine Biosciences, Inc. (NASDAQ: NBIX), Cirrus Logic, Inc (NASDAQ: CRUS), and AOL, Inc. (NYSE: AOL)FT: EU edges towards disclosing bank ‘stress tests’: France joined calls for the release of ‘stress test results’ on t… http://bit.ly/blwcWR

WSJ: Inspector general says MMS is carrying out its investigation of Gulf oil spill in a “completely backwards” manner. http://wsj.com

Daily Finance: BP’s Tony Hayward Is Set to Be ‘Sliced and Diced’ http://bit.ly/9NZwCc

CNN Money: S&P president: credit ratings matter, shouldn’t be mandatory http://bit.ly/9qWgDq

Yahoo! Finance: $BP shares may well rally, and if they do, consider taking advantage of any move up http://yhoo.it/bSMz8F

MarketWatch: #UK financial system gets unwound http://bit.ly/9FUha1

NYT DealBook: BP Shares Rise After Deal on Cleanup Costs http://nyti.ms/czkfoP

Douglas A. McIntyre

BP plc (NYSE: BP) is down again as the saga continues.  Fitch cut it sharply, its dividend is at risk, demands are being made for endless reimbursements and damages, and its CEO is supposed to meet with the White House.  Shares are down 4% at $30.15 on over 4 million ADR shares trading in the pre-market.

Curis Inc. (NASDAQ: CRIS) is getting spanked, and not lightly.  Its mid-stage colon cancer drug failed to show benefits as a first-line treatment in metastatic colorectal cancer.  Shares are down a sharp 39% at $1.98 versus a 52-week range of $1.28 to $3.70.

FedEx Corporation (NYSE: FDX) is trading lower despite earnings returning to strong profits.  The guidance for Fiscal May-2011 was offered as being $4.40 to $5.00 EPS versus Thomson Reuters estimates of $5.06 EPS.  Shares are down 2% at $81.47 on 200,000 shares.

Neurocrine Biosciences Inc. (NASDAQ: NBIX) is surging as it has a big deal on its hands with much larger Abbott Laboratories (NYSE: ABT).  Abbott has agreed to pay as much as $575 million to help develop and commercialize Neurocrine’s endometriosis treatment. Shares are up over 20% at $5.67 on 375,000 shares, a new 52-week high as the prior range was $1.94 to $5.20.

Nokia Corporation (NYSE: NOK) is getting hammered and is hitting 52-week lows on the ADR.  All the smartphone sales are beating out Nokia it appears as it lowered its devices and services for its second quarter 2010 outlook…. Shares are down 9.8% at $8.86 on over 15 million shares in pre-market trading.  The prior 52-week range was $9.10 to $16.00.

Somanetics Corp. (NASDAQ: SMTS) is surging on news that it is being acquired.  Covidien plc (NYSE: COV) announced a signed definitive merger agreement to acquire all of the outstanding shares of Somanetics Corporation for $25.00 per share in cash.  The total comes to $250 million, net of cash acquired. Somanetics is up over 31% at $24.87 on almost 2 million shares in the pre-market.  The prior 52-week range was $12.90 to $21.96.

Sonic Corp. (NASDAQ: SONC) lowered guidance… again.  Investors are going to probably going to get more than frustrated here if this happens again.  Shares are down 3% at $9.58 versus a 52-week range of $8.07 to $13.11.

Uranium Resources, Inc. (NASDAQ: URRE) must feel like the Lone Ranger.  It noted, “Tenth Circuit Rules in Favor of Uranium Resources, Inc. in Indian Country Case.”  Only 170,000 shares have traded, but it is up 46% at $0.73 versus a 52-week range of $0.45 to $1.55.

FANNIE MAE & FREDDIE MAC DELISTING

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Sponsor: 26 Cheap Stocks to Sell – Cheap stocks have been on a tear recently, but nine out of ten stocks are circling the drain!

Aixtron Aktiengesellschaft (NASDAQ: AIXG) is getting hit today, partly with ADRs and partly on an analyst downgrade from JPMorgan Cazenove.  Shares closed at $27.71 yesterday and are trading down 11.5% at $24.52 on about 20,000 shares.

The Bank of Ireland (NYSE: IRE) and Allied Irish Banks plc (NYSE: AIB) are being kicked yet again with the international markets.  Bank of Ireland (NYSE: IRE) ADRs are down 11.6% at $4.48 on close to 100,000 shares (new 52-week lows); Allied Irish Banks plc (NYSE: AIB) is down 11% at $2.23 on 150,000 shares (also a 52-week low for ADRs).

DiamondRock Hospitality Company (NYSE: DRH) has announced pricing of its secondary public offering of 20,000,000 common shares at a price of $8.40 per share.  Shares closed at $9.24 yesterday, and the stock is trading down around $8.35.  The 8:45 AM snapshot showed 90,000 shares and average volume is 1.577 million; the 52-week range is $5.11 to $11.77.

National Bank of Greece SA (NYSE: NBG) is a PIIGS leading cast member… ADRs are down 6% at $2.47 on analyst actions today.  The 52-week low is $2.44.

Neurocrine Biosciences Inc. (NASDAQ: NBIX) is soaring this morning after it reported that its endometriosis drug met its study goals.  Shares are up 50% at $4.10 on 150,000 shares.  Average volume is 411,000 shares and the old 52-week range was $1.94 to $3.67.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Sponsor: 5 best investments for 2010 – The next nine months represent a bold new era for investors.

We have included some basic color and news, as well as relative volume and the price moves where applicable.  Closing prices are snapshots right at 4:00 PM EST so these may be different from official closing prices posted after 4:30.

AEterna Zentaris, Inc. (NASDAQ: AEZS) was up after the FDA approved its Investigational New Drug (IND) application for doxorubicin targeted conjugate compound called AEZS-108 as a treatment to fight bladder cancer.  Shares closed up 14% at an unofficial closing price of $2.09 on over 21 million shares.  That is 7-times normal volume and the 52-week range is $0.75 to $3.25.

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) released additional preliminary data on a Phase 1b ACH-1625 trial in hepatitis C treatments.  Shares closed up 12.3% at $2.65 on right at 1 million shares.  Average volume is 222K and the 52-week range is $1.10 to $3.89.

Exelixis, Inc. (NASDAQ: EXEL) posted a strong recovery after having been lower on losses and job cuts.  Shares were up over 17% at $6.27 right at the bell.

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) looked like its names was Momentum Pharmaceuticals more than anything.  We saw over 500,000 shares trade and the unofficial closing bell price was up 11% at $13.85.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was also up in a mystery move… Shares were up almost 12% at $2.90 on actually light trading volume of 309,000 shares.  A seller’s strike.

OXiGENE, Inc. (NASDAQ: OXGN) was up 12% at $1.00 in a late day move after yesterday’s earnings report.

Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) rose and rose throughout the trading day.  What is odd is that there was a seller’s strike.  No sellers showed up for trading today.  There were only 118,000 shares traded at the 4PM close and the stock was up 11.7% at $6.12.  The 52-week range is $3.53 to $7.00.

Sequenom, Inc. (NASDAQ: SQNM) is of course in the testing space rather than in biotech… Its stock held up extremely well considering how deep of a discount it got a private placement off.  It raised more than $50 million in a private placement.

SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) was up ahead of a presentation next week with a company overview and business update.  Shares closed up 14.8% at $4.02 on 901,000 shares.

VIVUS, Inc. (NASDAQ: VVUS) was up again after yesterday’s late-day big bullish options trade.  Shares closed up 2.4% at $12.40 on almost 5.5 million shares.

Vical Incorporated (NASDAQ: VICL) was trading higher on word that its cancer drug showed promise in mid-stage trial results of Allovecton-7.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

• First Solar (FSLR) Raised to Buy at Merriman Curhan Ford.
• Janus Capital (JNS) Raised to Neutral at JPMorgan.
• Legg Mason (LM) Raised to Buy at Jefferies.
• Nalco (NLC) Raised to Overweight at JPMorgan.
• Neurocrine Bio (NBIX) Raised to Neutral at Piper Jaffray.
• Newmont Mining (NEM) Raised to Overweight at JPMorgan.
• Staples (SPLS) Raised to Market Perform at FBR.

Jon C. Ogg
October 30, 2008

CSK Auto (CAO) Company gets brokerage downgrade. Falls to $4.30 from 52-week high of $19.14.

Office Depot (ODP) Still falling after warning on sales. Drops to $14.11 from 52-week high of $41.06.

Neurocrine Biosciences (NBIX) FDA rejects company’s sleep drug. Shares off to $5.01 from 52-week high of $14.88.

NII Hldgs (NIHD) Company is participating in a December 18 third-generation license auction in Brazil. No other news. Falls to $43.37 from 52-week high of $90.43.

Conexant (CNXT) No news, but down to $.95 from 52-week high of $2.21.

AMD (AMD) Bad reaction to analyst day presentations. Falls to $8.42 from 52-week high of $23.

Douglas A. McIntyre